Radiopharm Theranostics Ltd earns nearly six-fold price upsi

Radiopharm Theranostics Ltd (ASX:RAD) (RAD) has earned a price valuation of $0.70 per share, an implied upside of nearly six times its current share price...

Related Keywords

Australia , London , City Of , United Kingdom , , Technology Organisation , Radiopharm Theranostics Ltd , Imperial College London , Bell Potter Securities Ltd , Cancer Research Technology Ltd , Research Agreement , Diamond Equity Research , Australia Nuclear Science , Diamond Equity , New York Based , Sponsored Research Agreement , Northstar Medical Radioisotopes , Nuclear Science ,